Тема: Взаимодействие белка комплемента C3 и его производных с пептидом ареницин-1

1.Зильбер Л. А. Основы иммунологии / Л. А. Зильбер. – М. : Медгиз, 1958. - 599 с.
2. Кокряков В. Н. Биология антибиотиков животного происхождения. – СПб.: Наука, 1999. – 162 с.
3. Кокряков В. Н. Очерки о врожденном иммунитете. – СПб.: Наука, 2006. - 261 с.
4. Остерман Л.А. Методы исследования белков и нуклеиновых кислот: Электрофорез и ультрацентрифугирование (практическое пособие) / Л.А. Остерман. – М.: Наука, - 1981. – 288 с.
5. Остерман, Л.А. Хроматография белков и нуклеиновых кислот / Л.А. Остерман. – М.: Наука, - 1985. – 563 с.
6. Умнякова Е. С. Модуляция системы комплемента антимикробными пептидами : дисс. ... канд. биол. наук : 14.03.03, 03.01.04 / Е. С. Умнякова. – СПб, 2017. – 152 с.
7. Умнякова Е. С., Пашинская Л. Д., Кренев И. А., Легковой С. В., Кокряков В. Н., Берлов М. Н. Заболевания, связанные с дисрегуляцией системы комплемента, и перспективы их лечения // Медицинский академический журнал. - 2018. - Т. 18, №3. - с. 7-16.
8. Arbore G., West E. E., Spolski R., Robertson A. A. B., Klos A., Rheinheimer C., Dutow P., Woodruff T. M., Yu Z. X., O’Neill L.A., Coll R. C., Sher A., Leonard W. J., Köhl J., Monk P., Cooper M. A., Arno M., Afzali B., Lachmann H. J., Cope A. P., Mayer-Barber K. D., Kemper K. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells // Science. – 2016. – V. 352, № 6292. – aad1210.
9. Atkinson J. P., Farries T. Separation of self from non-self in the complement system // Immunology today. – 1987. – V. 8, № 7/8. – P. 212—215.
10. Amara U., Flierl M. A., Rittirsch D., Klos A., Chen H., Acker B., Brückner, U. B., Nilsson B., Gebhard F., Lambris J. D., Huber-Lang M. Molecular intercommunication between the complement and coagulation systems // The journal of immunology. – 2010. – V. 185, № 9. – P. 5628—5636.
11. Andrä J., Jakovkin I., Grötzinger J., Hecht O. Krasnosdembskaya A. D., Goldmann T., Gutsmann T., Leippe M. Structure and mode of action of the antimicrobial peptide arenicin // Biochemical Journal - 2008, V. 410. - P. 113–122.
12. Bahar A., Ren D. Antimicrobial peptides // Pharmaceuticals. – V. 6, № 12. – P. 1543—1575.
13. Barbu A., Hamad O. A., Lind L., Ekdahl K. N., Nilsson B. The role of complement factor C3 in lipid metabolism // Molecular immunology. – 2015. – V. 67, № 1. – P. 101—107.
14. Barnum S. R. C3 / S. R. Barnum, T. Schein // The complement factsbook. – 2nd edition. – London : Academic Press, 2018. – Chapter 16. – P. 157—170.
15. Barnum S. R., Schein T. The complement system / S. R. Barnum, T. Schein // The complement factsbook. – 2nd edition. – London : Academic Press, 2018. – Chapter 2. – P. 7—20.
16. Bartόk I., Walport M. J. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3 // Journal of immunology. – 1995. – V. 154. – P. 5367—5375.
17. Bhat S., Song Y.–H., Lawyer C., Milner S.M. Modulation of the complement system by human beta-defensin 2 // J. Burns Wounds. Open Science Co. – 2007. – V.S. – P. e10.
18. Brown E.J. Interaction of Gram-Positive Microorganisms with Complement / Loos M. (eds) // Bacteria and Complement. Current Topics in Microbiology and Immunology, V. 121. Berlin, Heidelberg : Springer, 1985. - P. 159-187.
19. Catty D. Antibodies : a practical approach / D. Catty. - Oxford University Press, USA, - 1988. - 259 p.
20. Chaplin H. Review : the burgeoning history of complement system 1888—2005 // Immunohematology. – 2005. – V. 21, № 3. – P. 58—93.
21. Clas F., Schmidt G., Loos M. The Role of the Classical Pathway for the Bactericidal Effect of Normal Sera Against Gram-Negative Bacteria / Loos M. (eds) // Bacteria and Complement. Current Topics in Microbiology and Immunology, V. 121. Berlin, Heidelberg : Springer, 1985. - P. 19-72.
22. Cobraiville G., Fillet M., Sharif M., Ourradi K., Nys G., Malaise M. G., de Seny D. Validation of a new method by nano-liquid chromatography on chip tandem mass spectrometry for combined quantitation of C3f and the V65 vitronectin fragment as biomarkers of diagnosis and severity of osteoarthritis // Talanta. – 2017. – V. 169. – P. 170—180.
23. de Cordoba S. R., Hidalgo M. S., Pinto S., Tortajada A. Genetics of atypical hemolytic uretic syndrome (aHUS) // Seminars in Thrombosis and hemostasis. – 2014. – V., № 4. – P. 420—430.
24. Corigliano A., Preianò M., Terracciano R., Savino R., De Gori M., Galasso O., Gasparini G. C3f is a potential tool for the staging of osteoarthritis // Journal of biological regulators and homeostatic agents. – 2017. – V. 31, № 4 (suppl. 1). – P. 29—35.
25. Cravedi P., Leventhal J., Lakhani P., Ward S. C., Donovan M. J., Heeger P. S. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity // American journal of transplantion. – 2013. – V. 13, № 10. – P. 2530–2539.
26. Davis B.J. Disc electrophoresis II : Method and application to human serum proteins // Annal of the New York Academy of Sciences. – 1964. – Vol. 121, № 2. – P. 404—427.
27. Delanghe J. R., Speeckaert R., Speeckaert M. M. Complement C3 and its polymorphism : biological and clinical consequences // Pathology. – 2014. – V. 46, № 1. – P. 1—10.
28. Dempsey P. W., Allison M. E. D., Akkaraju S., Goodnow C. C., Fearon D. T. C3d of Complement as a Molecular Adjuvant : Bridging Innate and Acquired Immunity // Science. – 1996. – V. 271, № 5247. – P. 348–350
29. DiScipio R. G. The activation of the alternative pathway C3 convertase by human plasma kallikrein // Immunology. – 1982. – V. 45, № 3. – P. 587—595.
30. Ermini L., Goodship T. H. J., Strain L., Weale M. E., Sacks S. H., Cordell H. J., Fremeaux-Bacchi V., Sheerin N. S. Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS // Molecular immunology. – 2012. – V. 19, № 4. – P. 640—648.
31. Fearon D. T., Autsen K. F. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of the endogenous control proteins // Journal of experimental medicine. – 1977. – V. 146, № 1. – P. 22—23.
32. Ganu V. S., Müller-Eberhard H. J., Hugli T. E. Factor C3f is a spasmogenic fragment released from C3b by factors I and H : The heptadeca-peptide C3f was synthesized and characterized // Molecular immunology. – 1989. – V. 26, № 10. – P. 939—948.
33. Ghebrehiwet B., Müller-Eberhard H. J. C3e : an acidic fragment of human C3 with leukocytosis-inducing activity // The journal of immunology. – 1979. – V. 123, № 2. – P. 616—621.
34. Gilceson G. S. Complement-targeted therapies in lupus // Current Treatment Options in Rheumatology. - 2015. - V. 1, №1. - P. 10-18.
35. Groeneveld T.W.L., Ramwadhdoebé T.H., Trouw L.A., van den Ham P.L., van der Borden V., Drijfhout J.W., Hiemstra P.S., Daha M.R., Roos A. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation // Mol. Immunol. – 2007. – V. 44, № 14. – P. 3608–3614.
36. Hacobyan S, Boyajyan A., Sim R. B. Classical pathway complement activity in schizophrenia // Neuroscience Letters. – 2005. – V. 374, № 1. – P. 35—37.
37. Hancock R. E. W., Haney E. F., Gill E. E. The immunology of host defense peptides : beyond antimicrobial activity // Nature Reviews Immunology. – 2016. – V. 16, № 5. – P. 321—334.
38. Hess C., Kemper C. Complement-mediated regulation of metabolism and basic cellular processes // Immunity. – 2016. – V. 45, № 2. – P. 240—254.
39. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system // Science. – 2010. – V. 327, № 5963. – P. 291—295.
40. Jiménez-Reinoso A., Marin A. V., Regueiro J. R. Complement in basic processes of the cell // Molecular biology. – 2017. – V. 84. – P. 10—16.
41. Kazatchkine M. D., Fearon D. T., Austen K. F. Human alternative complement pathway : membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b // Journal of immunology. – 1979. – V. 122, № 1. – P. 75—81.
42. Kjældgaard A.-L., Pilely K., Olsen K. S., Pedersen S. W., Lauritsen A. Ø., Møller K., Garred P. Amyotrophic lateral sclerosis : The complement and inflammatory hypothesis // Molecular Immunology. – 2018. – V. 102. – P. 14—25.
43. Kolev M., Dimeloe S., Friec G. L., Navarini A., Arbore G., Povoleri G. A., Fischer M., Belle R., Loeliger J., Develioglu L., Bantug G. R., Watson J., Couzi L., Afzali B., Lavender P., Hess H., Kemper C. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses // Immunity. – 2015. – V. 42, № 6. – P. 1033—1047.
44. Kolev M., Ruseva M., Harris C., Morgan B., Donev R. Imolication of complement system and its regulators in Alzheimer’s disease // Current Neuropharmacology. – 2009. – V. 7, № 11. – P. 1—8.
45. Kopczynska M., Zelek W., Touchard S., Gaughran F., Di Forti M., Mondelli V., Murray R., O’Donovan M. C., Morgan B. P. Complement system biomarkers in first episode psychosis // Schizophrenia Research. – 2017.
46. Kopczynska M., Zelek W. M., Vespa S., Touchard S., Wardle M., Loveless S., Thomas R. H., Hamandi K., Morgan B. P. Complement system biomarkers in epilepsy // Seizure. – 2018. – V. 60. – P. 1—7.
47. Lachman P. J. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies // Journal of experimental medicine. – 1982. – V. 156, № 1. – P. 205—216.
48. Lachman, P. J. Looking back on the alternative complement pathway // Immunobiology. – 2018. – V. 223. - № 8/9. – P. 519—523.
49. Lalli P. N., Strainic M. G., Yang M., Lin F., Medof M. E., Heeger P. S. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis // Blood. – 2008. – V. 112, № 5. – P. 1759–66.
50. Laurence J. Atypical hemolytic uremic syndrome (aHUS) : making the diagnosis // Clinical advances in hematology and oncology. – 2012. – V. 10, № 10 (suppl. 17). – P. 1—12.
51. Lendak D., Mihajlovich D., Mitic G., Ubavic M., Novakov-Mikic A., Boban J., Brkic S. Complement component consumption in sepsis correlates better with hemostatic system parameters than with inflammatory biomarkers // Thrombosis Research. – 2018. – V. 170. – P. 126—132.
52. Li K., Gor J., Holers V. M., Storek M. J., Perkins S. J. Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d // Journal of Molecular Biology. - 2012. - V. 418, №3/4. - P. 248-263.
53. Li Y., Li Y., Chen T., Kuklina A. S., Bernard P., Esteva F. J., Shen H., Ferrari M., Hu Y. Circulating proteolytic products of carboxypeptidase N for early detection of breast cancer // Clinical Chemistry. – 2013 – V. 60, № 1. – P. 233—242.
54. Li H., Zhang Q., Li N., Wang F., Xiang H., Zhang Z., Su Y., Huang Y., Zhang S., Zhao G., Zhou R., Mao L., Lin Z., Cai W., Fang Y., Xie B., Zhao M., Hong W. Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia // Psychiatry Research. – 2016. – V. 246. – P. 700—706.
55. Liszevski M. K., Kolev M., Friec G. L., Leung M., Betram P. G., Fara A. F., Subias M., Pickering M. C., Drouet C., Meri S., Arstila T. P., Pekkatinen P. T., Ma M., Cope A., Reinheckel T., de Corboda S. R., Afzali B., Atkinson J. P., Kemper C. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation // Immunity. – 2013. – V. 39, № 6. – P. 1143—1157.
56. Markiewsky M. M., Nilsson B., Ekdahl K. N, Mollnes T. E., Lambris J. D. Complement and coagulation: strangers or partners in crime? // Trends in Immunology. – 2007. - V. 28, № 4. – P. 184–192.
57. Melis J. P. M., Strumane K., Ruuls S. R., Beurkens F. J., Schuurman J., Parren P. W. H. I. Complement in therapy and disease : regulating the complement system with antibody-based therapeutics // Molecular Immunology. - 2015. - V. 67, №2. - P. 117-130.
58. Merle N. S., Noé R., Halbwachs-Mecarelli L., Fremeaux-Bacchi V., Roumenina L. T. Complement system part II : role in immunity // Frontiers in immunology. – 2015. – V. 6. – 257.
59. Miyata T., Tokunaga F., Yoneya T., Yoshikawa K., Iwanaqa S., Niwa M., Takao T., Shimonishi Y. Antimicrobial peptides, isolated from horseshoe crab hemocytes, Tachyplesin II, and polyphemusins I and II : chemical structures and biological activity // The Journal pf Biochemistry. - 1989. - V. 106, №4. - P. 663-668.
60. Morgan B. P., Boyd C., Bubeck D. Molecular cell biology of complement membrane attack // Seminars in cell and developmental biology. – 2017. – V. 72. – P. 124—132.
61. Morgan B. P., Kopczynska M., Zelek W. M., Touchard S., O’Donovan M., Murray R., Mondelli V., Gaughran F. P. Complement system biomarkers in first episode psychosis // Molecular Immunology. – 2017. - V. 89. – P. 187.
62. Nakamura T., Furunaka H., Miyata T., Tokunaga F., Muta T., Iwanaga S., Niwa M., Takao T., Shimonishi Y. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus Tridentatus). Isolation and chemical structure // The Journal of Biological Chemistry. - 1988. - V. 263, №32. - P. 16709-16713.
63. Nesargikar P., Spiller B., Chavez R. The complement system : history, pathways cascade and inhibitors // European journal of microbiology and immunology. – 2012. – V. 2, № 2. – P. 103—111.
64. Nester C. M., Barbour T., de Cordoba S. R., Dragon-Durey M. A., Fremeaux-Bacchi V., Goodship T. H. J., Kavanagh D., Noris M., Pickering M., Sanchez-Corral P., Skerka C., Zipfel P., Smith R. J. H. Atypical aHUS : state of the art // Moleculat immunology. – 2015. – V. 67, № 1. – P. 31—42.
65. Nguyen L. T., Haney E. F., Vogel H. The expanding scope of antimicrobial peptide structures and their models of action // Trends in Biotechnology. – 2011. – V. 29, № 9. – P. 464—472.
66. Nichols E.-M., Barbour T. D., Pappworth I. Y., Wong E. K. S., Palmer J. M., Sheerin N. S., Pickering M. C., Marchbank K. J. An extended mini-complement factor H molecule ameliorates experimental C3-glomerulopathy // Kidney International. - 2015. - V. 88, №6. - P. 1314-1322.
67. Nilsson B., Ekdahl K. N. The tick-over theory revisited : is C3 a contact-activated protein? // Immunobiology. – 2012. – V. 217, № 11. – P. 1106—1110.
68. Nordahl E. A., Rydengård V., Nyberg P., Nitsche D. P., Mörgelin M., Malmsten M., Björck L., Schmidtchen A. Activation of complement system generates antibacterial peptides // Proceedings of the National Academy of Sciences. – 2004. – V. 101, № 48. – P. 16879—16884.
69. Oikonomopoulou K., DeAngilis R. A., Chen H., Diamandis E. P., Hollenberg M. D., Ricklin D., Lambris J. D. Induction of complement C3a receptor responses by kallikrein-related peptidase 14 // The journal of immunology. – 2013 – V. 191, № 7. – P. 3858—3866.
70. Ourradi K., Xu Y., de Seny D., Kirwan J., Blom A., Sharif M. Development and validation of novel biomarker assays for osteoarthritis // PLoS One. – 2017. – V. 12, № 7. – e0181334.
71. Ovchinnikova T. V., Aleshina G. M., Balandin S. V., Krasnosdembskaya A. D., Markelov M. L., Frolova E. I., Leonova Y. F., Tagaev A. A. Krasnodembsky E. G., Kokryakov V. N. Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina // FEBS Lett. - 2004. - V. 577. - P. 209–214.
72. Panyutich A. V., Szold O. H., Poon P. H., Tseng Y., Ganz T. Identification of defensing binding to C1 complement // FEBS Lett. – 1994. – V. 356, № 2/3. – P. 169–173.
73. Pasupuleti M., Walse B., Nordahl E. A., Mörgelin M., Schmidtchen A. Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans // Journal of biological chemistry. – 2006. – V. 282, № 4. – P. 2520—2528.
74. Presumey J., Bialas A. R., Carroll M. C. Complement system in neural synapse elimination in development and disease // Advances in Immunology. – 2017. – V. 135. – P. 53—79.
75. Profumo A., Mangerini R., Rubagotti A., Romano P., Damonte G., Guglielmini P., Facchiano A., Ferri F., Ricci F., Rocco M., Boccardo F. Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast // Journal of Proteomics. – 2013. – V. 85. – P. 44—52.
76. Prohászka Z., Német K., Csermely P., Hudecz F., Mezõ G., Füst G. Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gq41 of HIV-1 // Mol. Immunol. – 1997. – V. 34, № 11. – P. 809–816.
77. Qin X., Gao B. The complement system in liver diseases // Cell and molecular immunology. – 2006. – V. 3, № 5. – P. 333—340.
78. Rasmussen K. L., Nordestgaard B. G., Frikke-Schmidt R., Nielsen S. F. An updated Alzheimer hypothesis : Complement C3 and risk of Alzheimer’s disease – A cohort study of 95,442 individuals // Alzheimer’s & Dementia. – 2018.
79. Ricklin D., Hajishengallis G., Yang K., Lambris J. D. Complement: a key system for immune surveillance and homeostasis // Nature Immunology. – 2010. – V. 11, № 9. – P. 785–797.
80. Ricklin D., Reis E. S., Mastellos D. C., Gros P., Lambris J. D. Complement component C3 - the “Swiss Army Knife” of innate immunity and host defense // Immunological Reviews. – 2016. – V. 274, № 1. – P. 33—58.
81. Risitano A. M., Pascariello C., Selleri C., Vecchio L. D., Sica M., Fridkis-Hareli M., Mazsaroff I., Horvath C. J., Holers V. M. The human complement receptor type 2/factor H fusion protein TT30, an alternative pathway specific complement inhibitor, prevents hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria by membrane-targeting of factor H activity // Molecular Immunology. - 2010. - V. 67, №2. - P. 2215.
82. Sahu A., Morikis D., Soulika A. M., Spruce L., Moore W. T., Lambris J. D. Species specificity structural-functional analysis and biotransformation studies on compstatin, a potent complement inhibitor // Molecular Immunology, V. 35, №6/7. - P. 371.
83. Sahu A., Kay B. K., Lambris J. D. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library // The Journal of Immunology. - 1996. - V. 157. - P. 884-891.
84. Sethi S., Nester C. M., Smith R. J. H. Membrane proliferative glomerulonephritis and C3 glomerulopathy : resolving the confusion // Kidney international. – 2012. – V. 81, № 5. – P. 434—441.
85. Schägger H. von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa // Anal. Biochem. Academic Press. – 1987. – V. 166, № 2. – P. 368 – 379.
86. Sliwinsky A. J., Zvaifler N. J. Decreased synthesis of the third component of complement (C3) in hypocomplementic systemic lupus erythematosus // Clinical and experimental immunology. – 1972. – V. 11, № 1. – P. 21—29.
87. Stephan A. H., Barres B. A., Stevens B. The complement system : An unexpected role in synaptic pruning during development and disease // Annual Review of Neuroscience. – 2012. – V. 35, № 1. – P. 369—389.
88. Stevens B., Allen N. J., Vazquez L. E., Howell G. R., Christopherson K. S., Nouri N., Micheva K. D., Mehalow A. K., Huberman A. D., Stafford B., Sher A., Litke A. M., Lambris J. D., Smith S. J., John S. W. M., Barres B. A. The classical complement cascade mediates CNS synapse elimination // Cell. – 2007. – V. 131, № 6. – P. 1164—1178.
89. Strainic M. G., Liu J., Huang D., An F., Lalli P. N., Muqim N., Shapiro V. S., Dubyak G. R., Heeger P. S., Medof M. E. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells // Immunity. – 2008. – V. 28, №3. – P. 425–435.
90. Sun E. et al. Host defense (antimicrobial) peptides / E. Sun, C. R. Belanger, E. F. Haney, R. E. W. Hancock // Peptide applications in biomedicine, biotechnology and bioengineering. – 2018. – Chapter 2. – P. 253—285.
91. Swaak A. J. G., Hannema A., Vogelaar C., Boom F. A., van Es L., van Aalst R., van Eps L. W. S. Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes // Rheumatology international. – 1982. – V. 2, № 4. – P. 161—166.
92. Teisberg P. High voltage agarose electrophoresis in the study of C3 polymorphism // Vox sanguinis. – 1970. – V. 19, № 1. – P. 47—56.
93. Tomlinson S., Thurman J. M. Tissue-targeted complement therapeutics // Molecular Immunology. – 2018.
94. Welch T. R., Beischel L., Kleesattel A. Functional consequences of the genetic polymorphism of the third component of complement // The journal of pediatrics. – 1990. – V. 116, № 5. – P. S92—S97.
95. Wong E. K. S., Goodship T. H. J., Kavanagh D. Complement therapy in atypical haemolytic uraemic syndrome (aHUS) // Molecular immunology. – 2013. – V. 56, № 3. – P. 199—212.
96. Yang D. Anaphylotoxins / A. J. Kastin (ed.) // Handbook of biologically active peptides. – 2nd edition. – San Diego : Academic Press, 2013. – P. 625—530.
97. Yongqing T., Drentin N., Duncan R. C., Wijeyewickrema L. C., Pike, R. N. Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement : Two genes, five proteins and many functions? // Biochimica et Biophysica Acta - Proteins and Proteomics. – 2012. – V. 1824, № 1. – P. 253–262.
98. Zelek W., Fathalla B., Orme R. P., Morgan A., Touchard S., O’Hagan C., Loveless S., Robertson N., Morgan B. P. Complement system biomarkers in demyelinating disease // Immunobiology. – 2016a. – V. 221, № 10. – P. 1172.
99. Zelek W., Harris C. L., Topley Т., Weeks I., Lambie M., Davies S. J., Morgan B. P. Complement biomarkers in the management of peritoneal dialysis // Immunobiology. – 2016b. – V. 221, № 10. – P. 1172.
100. Zipfel P. F., Skerka C., Chen Q., Wiech T., Goodship T., Johnson S., Fremeaux-Bacchi V., Nester C., de Cόrdoba S. R., Noris M., Pickering M., Smith R. The role of complement in C3 glomerulopathy // Molecular immunology. – 2015. – V. 67, №1. – P. 21—30.
101. UniProtKB – P01024 (CO3_HUMAN) // UniProtKB: data resource. URL: https://www.uniprot.org/uniprot/P01024 (дата обращения: 14.10.2018).
102. URL: http://clinicaltrials.gov (дата обращения: 09.05.2019).

Купить